As opposed to the assumption that the stock market would have been flooded with new investments during the time from the fourth wave of the COVID-19 pandemic to the present, it had not been. When the stock market booms, the investors traditionally think of turning their capital to real estate. Under circumstances, buying properties offers lower risk, yields better returns and provides greater diversification which means to mix a wide variety of investments within a portfolio.
Vietnam’s benchmark VN-Index has surged 34.51 percent in the first half of this year, marking the highest increase in the world. Abundant cash flow, constantly increasing number of new investors and immediate measures to reduce congestion has propelled the stock market. The number of new investors entering the stock market in May scaled a new monthly record, with over 113,000 new trading accounts opened. The VN-Index’s continuous growth has broken most forecasts made by domestic securities companies.
As a result, more people are thinking of cashing out of stocks to buy real estate. After all, real estate is a real asset that provides utility and tends to hold its value. Stocks are just digital values that could plummet in value over night.
Not the least reason of which could make the market burgeon, Vietnam successfully negotiated to buy 170 million doses of COVID-19 vaccines that cover 70 percent of the population by this year. The ministry had said that it would not only seek multiple sources for the Covid-19 vaccines but also strive to be a part of the vaccine tech transfer process so Vietnam could produce the vaccines itself.
The health ministry has also reached an agreement with Russia to get 20 million doses of the Sputnik V vaccine within this year, though the exact time frames for the receipt have not been announced.
The ministry said it has also successfully struck deals with Moderna and Pfizer/BioNTech. Moderna said it would allow Asian pharmaceutical firm Zuellig Pharma to distribute five million doses to Vietnam in May, and HCMC has said it would purchase those doses.
Pfizer/BioNTech said it expects to provide Vietnam with around 31 million doses in the third and fourth quarters, with half the quantity delivered each quarter.